InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: 5TOP post# 4579

Sunday, 07/10/2016 8:52:12 PM

Sunday, July 10, 2016 8:52:12 PM

Post# of 232961
Very good synopsis/foresight with your post. Even with approving 100M AS and assuming they are utilized - you're still looking at marginal dilution because of the multibillion market the drug is targeting. The only negatives I see with this upcoming CC is dilution (which is to be expected), and further trial delays. Possible good news could be a number of different events: start of monotherapy, final patient injected for adjunct, start of GvHD trial, initiation of trials for breast or prostate cancer, partnership, licensing deal, etc. Stay tuned!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News